| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies |
| 08/27/2009 | US20090214612 Extracellular tnf inhibitors for treating cns disorders |
| 08/27/2009 | US20090214584 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis |
| 08/27/2009 | US20090214574 Anti-cd16 binding molecules |
| 08/27/2009 | US20090214573 Modulation of bne development |
| 08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
| 08/27/2009 | US20090214569 Use of HIV envelope/CD4 complexes for the generation antibodies |
| 08/27/2009 | US20090214566 Protective anti-glucan antibodies with preference for beta-1,3- glucans |
| 08/27/2009 | US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use |
| 08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
| 08/27/2009 | US20090214561 Treatment method |
| 08/27/2009 | US20090214560 Binding molecules to the human ox40 receptor |
| 08/27/2009 | US20090214559 Therapeutic Human Anti-IL-1R1 Monoclonal Antibody |
| 08/27/2009 | US20090214558 NOVEL MAdCAM ANTIBODIES |
| 08/27/2009 | US20090214557 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells |
| 08/27/2009 | US20090214556 Antibodies and related molecules that bind to 161p2f10b proteins |
| 08/27/2009 | US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases |
| 08/27/2009 | US20090214554 Truncated memapsin 2 compositions and treatments |
| 08/27/2009 | US20090214553 Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells |
| 08/27/2009 | US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
| 08/27/2009 | US20090214547 Binding member towards pneumolysin |
| 08/27/2009 | US20090214546 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214542 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214539 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 08/27/2009 | US20090214534 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY |
| 08/27/2009 | US20090214531 Methods and Compositions for Treating and Preventing Bacterial Infections |
| 08/27/2009 | US20090214528 Host cell lines for production of antibody constant region with enhanced effector function |
| 08/27/2009 | US20090214526 For use as antibody biodrug with improved therapeutic, production properties |
| 08/27/2009 | US20090214525 Novel anti-igf-ir antibodies and uses thereof |
| 08/27/2009 | US20090214523 Novel anti-IL13 antibodies and uses thereof |
| 08/27/2009 | US20090214520 Soluble CLCA-1 and antagonists to CLCA-1 |
| 08/27/2009 | US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214490 Human embryonic stem cell methods and podxl expression |
| 08/27/2009 | US20090214480 Novel cancer antigen peptide and the use thereof |
| 08/27/2009 | US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof |
| 08/27/2009 | US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof |
| 08/27/2009 | US20090214428 Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 08/27/2009 | US20090214423 Selective targeting of tumor vasculature using radiolabelled antibody molecules |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 08/27/2009 | US20090214101 Targeted Nanostructures for Cellular Imaging |
| 08/27/2009 | CA2844188A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2752851A1 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 08/27/2009 | CA2716280A1 Biomarkers |
| 08/27/2009 | CA2715632A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 08/27/2009 | CA2715324A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2714296A1 Humanized anti-c5ar antibodies |
| 08/27/2009 | CA2712474A1 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093237A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 08/26/2009 | EP2093236A1 Recombinant antibodies against vascular endothelial growth factor (vegf) |
| 08/26/2009 | EP2093233A1 Novel compositions and methods in cancer |
| 08/26/2009 | EP2092939A2 Therapeutical use of antibody inducing the production of cytokines |
| 08/26/2009 | EP2092938A1 Survivin-derived peptides and use thereof |
| 08/26/2009 | EP2092834A1 Methods and compositions of sphingolipid for preventing treating microbial infections |
| 08/26/2009 | EP2091975A2 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
| 08/26/2009 | EP2091974A1 Polypeptides specific for complexes involved in receptor-mediated signaling, such as the il-6/il-6 receptor complex |
| 08/26/2009 | EP2091973A2 Binary epitope antibodies and b cell superantigen immune stimulants |
| 08/26/2009 | EP2091972A1 Multi-modal cancer therapy using viral hitch-hiking |
| 08/26/2009 | EP2091971A2 Therapeutic targeting of escort proteins |
| 08/26/2009 | EP2091969A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 08/26/2009 | EP2091968A2 Il-21 variants |
| 08/26/2009 | EP2091564A2 Method of inhibiting coagulation with human anti-factor va antibodies and use thereof |
| 08/26/2009 | EP2032992B1 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
| 08/26/2009 | EP1718668B1 Antibody purification |
| 08/26/2009 | EP1711530B1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 08/26/2009 | EP1694705B1 Interleukin-10 antibodies |
| 08/26/2009 | EP1624891B1 Clotting factor-fc chimeric proteins to treat hemophilia |
| 08/26/2009 | EP1601694B1 Uses of il-23 antagonists; related reagents |
| 08/26/2009 | EP1561759B9 Cell death-inducing agent |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof |
| 08/26/2009 | EP1299524B1 Human myeloma cell line |
| 08/26/2009 | EP1296714B1 Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1200592B1 Mammalian cytokines; related reagents |
| 08/26/2009 | EP1066324B1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 08/26/2009 | EP1037977B1 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 08/26/2009 | EP1025218B9 Libraries of human antibody polypetides |
| 08/26/2009 | EP1007700B1 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 08/26/2009 | CN101517075A Cell death inducer |
| 08/26/2009 | CN101517068A Human monoclonal antibodies to activin receptor-like kinase-1 |
| 08/26/2009 | CN101516914A Antibodies against CCR5 and uses thereof |
| 08/26/2009 | CN101516913A Antibody having enhanced ADCC activity and method for production thereof |
| 08/26/2009 | CN101516912A Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same |
| 08/26/2009 | CN101516911A Humanized antibody against amyloid beta |
| 08/26/2009 | CN101516910A Bst2 inhibitor |
| 08/26/2009 | CN101516398A Antagonists of protease activated receptor-1 (PAR1) |
| 08/26/2009 | CN101516397A Treatment of multiple sclerosis (MS) with CAMPATH-1H |
| 08/26/2009 | CN101516394A Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 08/26/2009 | CN101514230A Monoclone antibody of ARD1 and application thereof |
| 08/26/2009 | CN100532558C Optimizing glycan processing in plants |
| 08/26/2009 | CN100532549C Genes and polypeptides relating to human colon cancers |
| 08/26/2009 | CN100531798C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/26/2009 | CN100531796C FGFR agonists |